Burden of Obesity in Psoriatic disease

المقدمة

سجل الان

Obesity is increasingly recognized as a key comorbidity in psoriatic disease, with important implications for both psoriasis (PsO) and psoriatic arthritis (PsA). Evidence shows that excess weight not only contributes to systemic inflammation but also worsens disease activity, reduces treatment response, and increases the risk of associated comorbidities such as cardiovascular disease and diabetes. Despite these links, obesity remains underrecognized and undertreated in patients with psoriatic disease.
This educational activity will explore the complex relationship between obesity, PsO, and PsA.

الأهداف

-at least 70% of learners will be able to accurately describe the relationship between obesity and increased disease activity in PsO and PsA, as measured by post-activity evaluation.

المتحدثين

Dr. Hussein Elbadawi

Consultant of Endocrinology, Diabetes & Metabolism Chairman of Diabetes & Metabolic Unit at “My Clinic” Medical Center Director of the Diabetes Management Program at “My Clinic” Medical Center

Dr Zeyad Al Zahrani

Consultant Rheumatologist - Section Head

King Khalid Medical City

Ministry of National Guard Health Affairs.

Dr. Abdullah Faisal Albadri

Consultant & Head of dermatology department at King Fahad General Hospital Jeddah, KSA. Dermatology Service Lead at Ministry of Health -Jeddah. German Board & Fellowship in Allergy, Vivantes Hospital, Charite University

DR.Yousef Binamer

MD,EMBA,FRCPC,DABD,FAAD
Chairman development of dermatology at King Faisal Specialist Hospital and Research Centre,Riyadh